beractant: Clinical Trials

11 trials of beractant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 2 unknown, 1 withdrawn. 4 Phase 2, 4 Phase 3, 3 Not applicable, 3 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Unknown 1
Phase 34Completed 2, Terminated 1, Unknown 1
Not applicable3Completed 2, Withdrawn 1
Phase 43Completed 1, Terminated 1, Unknown 1
Phase 11Completed 1

Follow beractant: new trials by email Literature Review of beractant trials Research Report on beractant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
Cadisurf, Survanta - Respiratory Distress Syndrome
Phase 2 / Phase 3UnknownRamesh K Agarwal9002016-06-012016-05-17
Aerosolized Surfactant in Neonatal RDS
Surfactant - Respiratory Distress Syndrome, Newborn
Phase 1 / Phase 2CompletedSood, Beena G., MD, MS1592014-12-012021-08-25
Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome
Curosurf®, Survanta® - Respiratory Distress Syndrome
Not applicableWithdrawnUniversity of Michigan2012-06-012014-01-08
Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide
exogenous surfactant - Respiratory Distress Syndrome
Phase 4CompletedEge University482012-03-012013-08-16
Perfusion Index Variability in Respiratory Distress Syndrome
Beractant, Poractant alfa - Poor Peripheral Perfusion
Not applicableCompletedDr. Sami Ulus Children's Hospital922011-08-012013-05-13
Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary Hemorrhage
Poractant alfa, Beractant - Pulmonary Hemorrhage
Not applicableCompletedDr. Sami Ulus Children's Hospital202010-03-012013-05-22
Prevention of Chronic Lung Disease (CLD) in Preterm Infants
budesonide, surfactant and air (placebo) - Respiratory Distress Syndrome, Chronic Lung Disease of Prematurity
Phase 4UnknownChina Medical University, China3002009-04-012012-08-08
A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants
Butantan, Control - Respiratory Distress Syndrome
Phase 2 / Phase 3CompletedUniversity of Sao Paulo3272005-04-012014-12-02
Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
Survanta (beractant), Curosurf (poractant) - Prematurity, Respiratory Distress Syndrome
Phase 4TerminatedAlan Fujii522005-01-012011-10-03
Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants
Early surfactant, Standard practice - Infant, Newborn, Respiratory Distress Syndrome
Phase 3TerminatedNICHD Neonatal Research Network612000-05-012015-06-08
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
Exosurf, Survanta - Infant, Newborn, Infant, Low Birth Weight
Phase 2 / Phase 3CompletedNICHD Neonatal Research Network6171991-01-012019-03-22

Conditions studied

Respiratory Distress Syndrome (8)  ·  Premature Birth (4)  ·  Bronchopulmonary Dysplasia (2)  ·  Ductus Arteriosus, Patent (1)  ·  Respiratory Distress Syndrome, Newborn (1)  ·  Respiratory Insufficiency (1)

Sponsors

Dr. Sami Ulus Children's Hospital (2)  ·  NICHD Neonatal Research Network (2)  ·  Alan Fujii (1)  ·  China Medical University, China (1)  ·  Ege University (1)  ·  Ramesh K Agarwal (1)  ·  Sood, Beena G., MD, MS (1)  ·  University of Michigan (1)  ·  University of Sao Paulo (1)

Countries

United States (5)  ·  Turkey (Türkiye) (2)  ·  Brazil (1)  ·  China (1)

Top investigators

Avroy A. Fanaroff, MD (2)  ·  Barbara J. Stoll, MD (2)  ·  Charles R. Bauer, MD (2)  ·  David K. Stevenson, MD (2)  ·  Edward F. Donovan, MD (2)  ·  James A. Lemons, MD (2)  ·  Jon E. Tyson, MD MPH (2)  ·  Seetha Shankaran, MD (2)  ·  Sheldon B. Korones, MD (2)  ·  Alan M Fujii, MD (1)  ·  Alexander R Precioso, MD PhD (1)  ·  Beena G. Sood, MD, MS (1)  ·  Celso M Rebello, MD PhD (1)  ·  Dilek Dilli, Assoc Prof (1)  ·  Elizabeth C. Wright, PhD (1)

Results publications

PMID 19956811, PMID 20336076, PMID 20336077, PMID 25628188, PMID 26351971, PMID 31485014, PMID 33338661, PMID 8095608, PMID 8229487

NIH funding

U10HD021364 (2), U10HD021385 (2), U10HD021397 (2), U10HD021415 (2), U10HD027851 (2), U10HD027853 (2), U10HD027856 (2), U10HD027871 (2), U10HD027880 (2), U10HD027881 (2), M01RR000070 (1), M01RR000750 (1), M01RR000997 (1), M01RR001032 (1), M01RR006022 (1)